a8387f
FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For the
month of March
2020
Commission
File Number: 001-11960
AstraZeneca PLC
1
Francis Crick Avenue
Cambridge
Biomedical Campus
Cambridge
CB2 0AA
United
Kingdom
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F X Form 40-F __
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ______
Indicate
by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities
Exchange Act of 1934.
Yes __
No X
If
“Yes” is marked, indicate below the file number
assigned to the Registrant in connection with Rule 12g3-2(b):
82-_____________
AstraZeneca PLC
INDEX
TO EXHIBITS
12 March 2020 11:00 GMT
Notice of Annual General Meeting
AstraZeneca PLC (the Company) announced today the publication of
its Notice of Annual General Meeting 2020 and Shareholders'
Circular (the Notice).
The Notice has been submitted to the National Storage Mechanism and
will shortly be available for inspection at
www.morningstar.co.uk/uk/nsm. The Notice is also available on the
Company's website at www.astrazeneca.com/agm.
The Company's Annual Report and Form 20-F Information 2019 was
published on 3 March 2020.
The Notice is being despatched to shareholders today.
The meeting place for the Annual General Meeting (AGM) will be
Leonardo Royal Hotel London Tower Bridge, 45 Prescot St, London, E1
8GP and the AGM will commence at 2.30 pm (BST) on 29 April
2020.
The Company continues to monitor the situation in relation to
COVID-19 and will notify shareholders via our
website, www.astrazeneca.com as
soon as practicably possible if there are any changes to the AGM
arrangements. Shareholders are reminded of their right to
appoint the Chairman of the AGM, or any other person, as their
proxy to attend the meeting and vote on their
behalf.
AstraZeneca
AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led
biopharmaceutical company that focuses on the discovery,
development and commercialisation of prescription medicines,
primarily for the treatment of diseases in three therapy areas -
Oncology, Cardiovascular, Renal and Metabolism, and Respiratory.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries
and its innovative medicines are used by millions of patients
worldwide. Please visit astrazeneca.com and
follow the Company on Twitter @AstraZeneca.
Media Relations
|
|
|
Gonzalo
Viña
|
|
+44 203 749 5916
|
Rob
Skelding
|
Oncology
|
+44 203 749 5821
|
Rebecca
Einhorn
|
Oncology
|
+1 301 518 4122
|
Matt
Kent
|
BioPharmaceuticals
|
+44 203 749 5906
|
Angela
Fiorin
|
BioPharmaceuticals
|
+44 1223 344 690
|
Jennifer
Hursit
|
Other
|
+44 203 749 5762
|
Christina
Malmberg Hägerstrand
|
Sweden
|
+46 8 552 53 106
|
Michele
Meixell
|
US
|
+1 302 885 2677
|
Investor Relations
|
|
|
Thomas
Kudsk Larsen
|
|
+44 203 749 5712
|
Henry
Wheeler
|
Oncology
|
+44 203 749 5797
|
Christer
Gruvris
|
BioPharmaceuticals
(Cardiovascular, Metabolism)
|
+44 203 749 5711
|
Nick
Stone
|
BioPharmaceuticals (Renal) Environmental, Social and
Governance
|
+44 203 749 5716
|
Josie
Afolabi
|
BioPharmaceuticals (Respiratory)
|
+44 203 749 5631
|
Tom
Waldron
|
Other medicines
|
+44 7385 033 717
|
Craig
Marks
|
Finance
Fixed income
|
+44 7881 615 764
|
Jennifer
Kretzmann
|
Corporate access
Retail investors
|
+44 203 749 5824
|
US
toll-free
|
|
+1 866 381 72 77
|
Adrian Kemp
Company Secretary
AstraZeneca PLC
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
Date:
12 March
2020
|
By: /s/
Adrian Kemp
|
|
Name:
Adrian Kemp
|
|
Title:
Company Secretary
|